Glycocalyx Biomarkers as Early Predictors of Endotheliopathy in Pediatric and Young Adult Hematopoietic Stem Cell Transplantation Patients - Takeaways - MDSpire

Glycocalyx Biomarkers as Early Predictors of Endotheliopathy in Pediatric and Young Adult Hematopoietic Stem Cell Transplantation Patients

  • By

  • Uchida, Kimberly

  • Mahadeo, Kris Michael

  • McArthur, Jennifer Ann

  • Avent, Yvonne

  • Hsu, Chia-Wei

  • Pan, Haitao

  • Elbahlawan, Lama

  • Hines, Melissa R

  • Sharma, Akshay

  • Tatevossian, Ruth G

  • Mahapatra, Sebabrata

  • Kumbaji, Meenasri

  • Sheikh, Irtiza

  • Li, Ying

  • Schadler, Keri

  • Ghafoor, Saad

  • April 13, 2026

  • 0 min

Share

  • 1

    Glycocalyx biomarkers may predict endotheliopathy in pediatric and young adult patients post-hematopoietic stem cell transplantation.

  • 2

    The study compared biomarker concentrations in HSCT patients with and without endotheliopathy at specific intervals.

  • 3

    Syndecan-1 and Angiopoietin-2 levels differed significantly between endotheliopathy cases and controls at multiple time points.

  • 4

    TIMP-1 and IGFBP-3 showed perfect predictive performance for endotheliopathy in the MDACC study.

  • 5

    Further research is needed to confirm these findings due to the limited sample size and implications for generalizability.

Original Source(s)

Related Content